[Safety and feasibility of dobutamine-atropine stress echocardiography].
OBJECTIVE
To study the safety and feasibility of dobutamine-atropine stress echocardiography (DASE) in patients with known or suspected coronary artery disease.


METHODS
There were 3,000 DASE that were studied in a prospective fashion. All symptoms and side effects were stored in a data base format.


RESULTS
Major test-related complications observed included one case of myocardial infarction, four cases of sustained ventricular tachycardia and five cases of atropine intoxication. There was no death or ventricular fibrillation as a direct or indirect consequence of the test. The infusion protocol allowed to us to examine patients using beta blockers, and led to 95% feasibility.


CONCLUSIONS
DASE is a safe and feasible method for the study of patients with suspected or known coronary artery disease.
Mathias Júnior
W
W
Escola Paulista de Medicina, UNIFESP, São Paulo.
Beneti
L P
LP
dos Santos
F C
FC
Duprat
R
R
Beraldo
A
A
Gil
M A
MA
Andrade
J L
JL
Martinez
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001285:Atropine / Q000009:adverse effects; D002316:Cardiotonic Agents; D002648:Child; D002675:Child, Preschool; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D004280:Dobutamine / Q000009:adverse effects; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D014463:Ultrasonography
D002316:Cardiotonic Agents; D004280:Dobutamine; D001285:Atropine
Segurança e exeqüibilidade da ecocardiografia com estresse pela dobutamina associada à atropina.